Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ENDRA Life Sciences Inc.
< Previous
1
2
Next >
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 22, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Reverse Stock Split
August 16, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
August 13, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Leadership Changes
August 13, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14
August 07, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
June 04, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Provides Update Following In-person Meeting with FDA
May 20, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
May 14, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
May 07, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
May 02, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 28, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024
March 21, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Installs First TAEUS System in the UK
February 27, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System
February 21, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe
February 14, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
November 29, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
November 27, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
November 08, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
November 07, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
November 06, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
September 07, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
August 30, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
August 23, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
August 14, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA
August 14, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023
August 01, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023
July 06, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
Study Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023
June 07, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
May 15, 2023
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.